Cat — Persian — MSK
FDA Report #N141502 — September 2, 2025
Animal Information
| Species | Cat |
| Breed | Persian |
| Gender | Male |
| Age | 2.00 Month |
| Weight | 1.451 Kilogram |
Drug Information
| Brand Name | MSK |
| Active Ingredients | Selamectin;Sarolaner |
| Manufacturer | MSK |
Reactions
Emesis (multiple); Lethargy (see also Central nervous system depression in Neurological); Not himself/herself; Decreased appetite; Weight loss; Enlarged kidney(s); Hyperglycaemia; Elevated blood urea nitrogen (BUN); Hyperphosphataemia; Hyponatremia; Hyperkalaemia; Hypochloraemia; Elevated cholesterol (total); Decreased mean corpuscular volume (MCV); Elevated mean corpuscular haemoglobin concentration (MCHC); Elevated red cell distribution width (RDW); Eosinopenia; Thrombocytosis
Outcome
Ongoing
Onset Date
September 2, 2025